Mechanism of miR-135a/b on regulating cisplatin resistance of human lung cancer cell line A549/CDDP

Zhou Li,Qiu Tianzhu,Chen Wenjiao,Zhu Wei,Shu Yongqian,Liu Ping
DOI: https://doi.org/10.7655/NYDXBNS20130406
2013-01-01
Abstract:Objective:To investigate whether miR-135a/b could modulate the drug resistance of the human lung cancer cell line A549/CDDP to cisplatin(CDDP),and explore the mechanism of miR-135a/b on the CDDP sensitivity of A549/CDDP cells.Methods: MiR-135a/b expression was measured by quantitative real-time PCR.Transient transfection was used in A549 and A549/CDDP cell lines.Cell viability was detected by MTT assay.MCL1 3’-untranslated region-based luciferase reporter plasmids was constructed to testify the target gene of miR-135a/b.Protein expressions were measured by western blot.Flow cytometry was used to detect CDDPinduced apoptosis.Results:We found that miR-135a/b were downregulated while MCL1 was upregulated in A549/CDDP cells,compared with the parental A549 cells.In vitro drug sensitivity assay demonstrated that the over-expression of miR-135a/b sensitized A549/CDDP cells to cisplatin.The luciferase activity of MCL1 3’-untranslated region-based reporter constructed in A549/CDDP cells suggested that MCL1 was the direct target gene of miR-135a/b.Enforced miR-135a/b expression reduced MCL1 protein level and sensitized A549/CDDP cells to CDDP-induced apoptosis.Conclusion:This study demonstrated that hsa-miR-135a/b could play a role in the development of CDDP resistance in lung cancer cell line at least in part by modulation of apoptosis via targeting MCL1.
What problem does this paper attempt to address?